With 4.21 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.27 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.2 whereas the lowest price it dropped to was $1.77. The 52-week range on APM shows that it touched its highest point at $7.49 and its lowest point at $0.46 during that stretch. It currently has a 1-year price target of $80.00. Beta for the stock currently stands at -0.35.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of APM was up-trending over the past week, with a rise of 111.83%, but this was up by 74.34% over a month. Three-month performance surged to 82.41% while six-month performance rose 60.16%. The stock lost -29.64% in the past year, while it has lost -56.51% so far this year.
Float and Shares Shorts:
At present, 7.14 million APM shares are outstanding with a float of 4.31 million shares on hand for trading. On 2025-06-13, short shares totaled 84548.0, which was 117.999995 higher than short shares on 1747267200. In addition to Mr. Chung Yuen Huen as the firm’s Founder, CEO & Executive Director, Mr. Kwok Kuen Wong serves as its Head of Finance.
Institutional Ownership:
Through their ownership of 0.01763 of APM’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.7 being high and -$0.7 being low. For APM, this leads to a yearly average estimate of -$0.7.
